SCHEMBL26311771

SCHEMBL26311771

CC1CN(C)C[C@H](C)N1c1cc(NC(=O)OC(C)(C)C)c(Cl)c(F)n1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 13/20 0.43
▸ BCL6 P41182 15/20 0.41
▸ NCOR2 Q9Y618 6/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22569530 1.00 FPR2 (0.43) FPR2BCL6NCOR2
SCHEMBL30595762 1.00 FPR2 (0.43) FPR2BCL6NCOR2
SCHEMBL21262022 1.00 FPR2 (0.43) FPR2BCL6NCOR2
SCHEMBL30595766 1.00 FPR2 (0.43) FPR2BCL6NCOR2
SCHEMBL21262062 0.88 BCL6 (0.46) FPR2BCL6NCOR2
SCHEMBL22578920 0.85 FPR2 (0.47) FPR2BCL6NCOR2
SCHEMBL22578856 0.85 FPR2 (0.47) FPR2BCL6NCOR2
SCHEMBL21262182 0.85 HRH4 (0.35) FPR2
SCHEMBL22569407 0.81 HDAC1 (0.35) FPR2
SCHEMBL21262198 0.80 FPR2 (0.40) FPR2BCL6NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728267-B1 TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RES OICR (CA) 2023-09-13 — — EP disclosed
Send feedback